| 000 | 01501 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514004804.0 | ||
| 264 | 0 | _c20010830 | |
| 008 | 200108s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800100295 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoddy, A V | |
| 245 | 0 | 0 |
_aPharmacological study of paclitaxel duration of infusion combined with GFR-based carboplatin in the treatment of ovarian cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _cJul 2001 |
||
| 300 |
_a15-21 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aGriffin, M J | |
| 700 | 1 | _aSludden, J | |
| 700 | 1 | _aThomas, H D | |
| 700 | 1 | _aFishwick, K | |
| 700 | 1 | _aWright, J G | |
| 700 | 1 | _aPlumner, E R | |
| 700 | 1 | _aHighley, M | |
| 700 | 1 | _aCalvert, A H | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 48 _gno. 1 _gp. 15-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800100295 _zAvailable from publisher's website |
| 999 |
_c11415369 _d11415369 |
||